Beijing Scitop Bio-tech Co Ltd
SZSE:300858
Gross Margin
Beijing Scitop Bio-tech Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 3.9B CNY |
| Gross Margin |
53%
|
| Country | JP |
| Market Cap | 53.2T JPY |
| Gross Margin |
34%
|
| Country | CH |
| Market Cap | 256.9B CHF |
| Gross Margin |
46%
|
| Country | US |
| Market Cap | 91.1B USD |
| Gross Margin |
42%
|
| Country | FR |
| Market Cap | 38.5B EUR |
| Gross Margin |
47%
|
| Country | US |
| Market Cap | 41.7B USD |
| Gross Margin |
34%
|
| Country | US |
| Market Cap | 39.6B USD |
| Gross Margin |
46%
|
| Country | US |
| Market Cap | 38.1B USD |
| Gross Margin |
35%
|
| Country | CN |
| Market Cap | 255.8B CNY |
| Gross Margin |
2%
|
| Country | ZA |
| Market Cap | 30.6B Zac |
| Gross Margin |
28%
|
| Country | ZA |
| Market Cap | 29.2B Zac |
| Gross Margin |
40%
|
Profitability Report
View the profitability report to see the full profitability analysis for Beijing Scitop Bio-tech Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Beijing Scitop Bio-tech Co Ltd's most recent financial statements, the company has Gross Margin of 53.3%.
You don't have any saved screeners yet
